Skip to main content
Premium Trial:

Request an Annual Quote

Athersys Wins Diabetes Grant from JDRF

This article has been corrected. A previous version erroneously stated that the JDRF program had $600 million. The JDRF said it does not release the dollar figure on research funding available under its program. GenomeWeb regrets the error.

 

NEW YORK, June 4 (GenomeWeb News) - Cleveland, Ohio-based Athersys announced today that it has received a grant from the Juvenile Diabetes Research Foundation to use its protein expression and stem cell technology to look for proteins that promote the formation of pancreatic islet cells.

 

The grant was provided as part of JDRF's Industry Discovery and Development Partnership Program. William Lehman, executive vice president, corporate development and finance of Athersys, said that the value of the grant was "in the six figures."

 

Athersys will use its RAGE protein expression technology with its MAPC adult stem cell technology to identify, isolate, and characterize proteins that cause the differentiation of stem cells into pancreatic islet cells.

 

Athersys has developed RAGE and GECKO - which stands for genome-wide cell-based knockout technology - for use in drug target validation and therapeutic development applications.

 

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.